Bonamour, Inc. (fka BONI)

[Madkins]

Bonamour, Inc., (OTCQB:BONI) announced today that the Company has
received its Certificate of Free Sale issued by the Personal Care
Products Counsel confirming that Bonamour products comply with all
applicable state and federal guidelines in the United States of America.
This certification is required by many Asian and European countries to
facilitate the approval process for export of Bonamour products to such
countries.

On December 17th, 2013, the Company announced it received CFS
Certification for Singapore and Vietnam. The recent certification of
Malaysia is an important milestone in the marketing strategy for
Bonamour International, LLC, the Company’s sales affiliate and marketing
arm and sales network.





Bonamour, Inc. products are manufactured in compliance with all local
and state laws and regulations and the Federal Food, Drug and Cosmetic
Act, and, Bonamour, Inc. products are permitted to be sold in interstate
commerce throughout the United States. In the United States, such skin
care products are legally classified as cosmetics, and the U.S. Food and
Drug Administration (FDA) has not promulgated Good Manufacturing
Practice regulations (GMP’s) for cosmetics. However, the Personal Care
Products Council (formerly CTFA) has issued Technical Guidelines in the
areas of quality assurance, microbiology, and pharmacology/toxicology,
as guidance documents in lieu of formal cosmetic GMPs in keeping with
the U.S. cosmetic industry’s commitment in the area of self-regulation.

“We are pleased to announce the addition of Malaysia to our CFS
Certification list and we are currently working to receive approval for
Thailand as well. Malaysia and Thailand have similar consumer
demographics to Hong Kong where we enjoyed great success during a test
market launch of our Rejuvenating Trio product line,” said Nathan
Halsey, CEO of Bonamour, Inc.

About Bonamour, Inc.:

Bonamour, Inc. is a Dallas-based developer and brand owner of a high end
line of anti-aging skin care products often referred to as
cosmeceuticals. The Company's products are marketed and sold through its
affiliate and sales arm, Bonamour International, LLC. Bonamour
International is focused on building a network marketing and direct
sales/distribution organization for the Bonamour brand in Asia. The
Company's target markets are comprised of nearly three billion people,
many of whom are experiencing rapidly rising personal incomes and a
strong affinity for U.S. made luxury goods. For additional information
log on to www.bonamour.com.

Safe Harbor

This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended that
represent the company's current expectations and beliefs. All statements
other than statements of historical fact are "forward-looking
statements" for purposes of federal and state securities laws and
include, but are not limited to, statements of management's expectations
regarding the company's performance, initiatives, goals, strategies and
new product introductions; statements of projections regarding
international sales targets and goals in Asia including Mainland China;
statements of belief; and statements of assumptions underlying any of
the foregoing. In some cases, you can identify these statements by
forward-looking words such as "believe," "expect," "project,"
"anticipate," "estimate," "intend," "plan," "targets," "likely," "will,"
"would," "could," "may," "might," the negative of these words and other
similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed
herein. These risks and uncertainties include, but are not limited to,
the following:

-- any changes in operations or future financial results from those
currently anticipated;

-- any failure of current or planned initiatives or products to generate
interest among distributors and customers and generate sponsoring and
selling activities on a sustained basis;

-- risks related to accurately predicting, delivering or maintaining
sufficient quantities of products to support our planned initiatives or
launch strategies, including possible ingredient supply limitations;

-- risk of foreign currency fluctuations and the currency translation
impact on the company's business associated with these fluctuations;

-- regulatory risks associated with the company's products, which could
require the company to modify its claims or inhibit the company's
ability to import or continue selling a product in a market if it is
determined to be a medical device or if it is unable to register the
product in a timely manner under applicable regulatory requirements;

-- any inability to secure necessary governmental approvals or licenses
to effect any future changes or expansion;

-- regulatory scrutiny and investigations in target markets in Asia and
other foreign markets, that could in the future, negatively impact the
company's business, including the interruption of sales activities in
stores, loss of licenses, and the imposition of fines;

-- adverse publicity related to the company's business, products,
industry or any legal actions or complaints by distributors or others;
and

-- continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of
associated risks set forth in the documents filed by the company with
the Securities and Exchange Commission. The forward-looking statements
set forth the company's beliefs as of the date that such information was
first provided and the company assumes no duty to update the
forward-looking statements contained in this release to reflect any
change except as required by law.

http://www.otcdynamics.com/bonamour-receives-cfs-certification-from-the-personal-care-products-council-for-export-registration-for-malaysia